Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents

The corona virus disease 2019 (COVID-19) pandemic has till date (26/7/20) affected 1crore 62 lac 73 thousand 638 people globally with almost 6.5 lakh mortalities. COVID-19 has invaded the operation theatre and intensive care unit (ICU) in a short span of 6 months. It appears inevitable that all of u...

Full description

Bibliographic Details
Main Authors: Shagun B Shah, Uma Hariharan, Rajiv Chawla
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Journal of Anaesthesiology Clinical Pharmacology
Subjects:
anesthetic drugs
azithromycin
covid-19
dexamethasone
favipiravir
hydroxychloroquine
ivermectin
nitazoxanide
remdesivir
ritonavir
tocilizumab
Online Access:http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shah

Internet

http://www.joacp.org/article.asp?issn=0970-9185;year=2021;volume=37;issue=2;spage=160;epage=170;aulast=Shah

Similar Items